Multidrug-Resistant Hypervirulent Klebsiella pneumoniae Found Persisting Silently in Infant Gut Microbiota

I Y Vasilyev1, I V Nikolaeva2, M N Siniagina1

  • 1Institute of Fundamental Medicine and Biology, Federal University, 420008 Ulitsa Kremlyovskaya 18, Kazan, Russia.

Insights

Multidrug-resistant Klebsiella pneumoniae (MDRKP) strains were found in healthy neonates. Some isolates possessed hypervirulent genes, posing a potential risk even to healthy individuals, though the source remains unknown.

Area of Science:

  • Microbiology
  • Genomics
  • Infectious Diseases

Background:

  • Multidrug-resistant Klebsiella pneumoniae (MDRKP) poses a significant threat, particularly to immunocompromised individuals.
  • The emergence of hypervirulent MDRKP strains presents a novel challenge, potentially affecting even healthy populations.
  • Understanding the genetic basis and transmission dynamics of MDRKP is crucial for public health.

Purpose of the Study:

  • To investigate the emergence of nonoutbreak MDRKP isolates in healthy neonates at a maternity hospital in Kazan, Russia.
  • To characterize the antimicrobial resistance determinants and pathogenic potential of these isolates using whole-genome sequencing.
  • To identify the phylogenetic relationships and potential sources of MDRKP transmission within the hospital setting.

Main Methods:

  • Collection and phenotypic characterization of ten MDRKP isolates from eight healthy neonates.
  • Antimicrobial susceptibility testing including microdilution assays.
  • Whole-genome shotgun (WGS) sequencing for comprehensive genetic analysis.
  • Pangenome analysis and in silico multilocus sequence typing (MLST) for phylogenetic classification.

Main Results:

  • All ten isolates exhibited multidrug resistance, including resistance to extended-spectrum beta-lactamases (ESBLs) and various antibiotic classes.
  • WGS identified genes conferring resistance to aminoglycosides, fluoroquinolones, macrolides, sulfonamides, chloramphenicols, tetracyclines, and trimethoprim.
  • Pangenome analysis revealed two distinct phylogenetic clades; one clade (ST23) carried genes associated with hypervirulence (yersiniabactin, aerobactin, salmochelin, colibactin, hypermucoid factors, specific K- and O-antigens).
  • The source of the MDRKP spread could not be determined, and infected infants remained asymptomatic.

Conclusions:

  • The study identified MDRKP strains with hypervirulent potential in healthy neonates, highlighting a potential emerging public health concern.
  • Despite the presence of virulence factors, the infected infants showed no clinical signs of disease.
  • Further investigation is needed to elucidate the transmission dynamics and clinical implications of hypervirulent MDRKP in neonatal populations.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
844
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
130
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
120